Oliver Kemp, CEO of Prostate Cancer Research, Director of PCR Inc, Chair at Health Poverty Action, shared on LinkedIn:
“It’s time to get far bolder in the way we approach cancer. After half a decade we have arrived at a milestone.
Starting next week 500,000 invites are going out to almost everybody with prostate cancer. Alongside NHS England we will usher in a generation of new less aggressive treatments, better diagnostics and personalized fast access to appropriate clinical trials.
This will be the first time anyone will link ongoing patient experience to what treatments people are on at this kind of scale anywhere in the world.
Time for data to work for the people who need it. Please join if you get an invite.”
You can also read: ‘Adaptive MR-Guided SBRT Shows Low Toxicity in Prostate Cancer‘
